Cardiovascular Disease in Patients with Diabetes: A Comparison of Professional Society Guidelines

被引：2
作者：
Salazar, Ilton M. Cubero [1 ,2 ]
Tibuakuu, Martin [1 ,2 ]
Blumenthal, Roger S. [1 ,2 ]
Sarkar, Sudipa [1 ,3 ]
机构：
[1] Johns Hopkins Univ Hosp, Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Di, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ Hosp, Dept Med, Div Cardiol, Baltimore, MD 21287 USA
[3] Johns Hopkins Univ Hosp, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD 21287 USA
来源：
CURRENT DIABETES REVIEWS | 2022年 / 18卷 / 04期
关键词：
Diabetes; cardiovascular disease; hypertension; atherosclerosis; hyperlipidemia; AMERICAN-COLLEGE; STATIN THERAPY; RISK; OUTCOMES; ASSOCIATION; EZETIMIBE; EFFICACY; DESIGN; SAFETY;
D O I：
10.2174/1573399817666210820105514
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this review, we compare major points given in the 2021 American Diabetes Association and the 2020 American Association of Clinical Endocrinologists/American College of Endocrinology guidelines, in particular, the assessment and management of cardiovascular risk in patients with diabetes with a focus on dyslipidemia, blood pressure, and pharmacotherapy in diabetes.
引用
收藏
页数：7
相关论文
共 50 条
[31]   Genotyping and phenotyping of Haptoglobin gene polymorphisms and their correlation with cardiovascular disease and biochemical parameters in Iranian patients with type 2 diabetes mellitus [J].
Khodarahmi, Ameneh ;
Ghanbarzadeh, Fatemeh ;
Hemati, Mahdie ;
Bishomar, Elaheh ;
Salehi-Abargouei, Amin ;
Moradi, Ali .
HUMAN GENE, 2024, 40
[32]   Exploring the Complex Connection Between Diabetes and Cardiovascular Disease: Analyzing Approaches to Mitigate Cardiovascular Risk in Patients With Diabetes [J].
Jyotsna, Fnu ;
Ahmed, Areeba ;
Kumar, Kamal ;
Kaur, Paramjeet ;
Chaudhary, Mitul Hareshkumar ;
Kumar, Sagar ;
Khan, Ejaz ;
Khanam, Bushra ;
Shah, Syeda Urooba ;
Varrassi, Giustino ;
Khatri, Mahima ;
Kumar, Satesh ;
Kakadiya, Kishan Ashokbhai .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
[33]   An estimation of the consequences of reinforcing the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society guidelines on current lipid-lowering treatment in patients with type 2 diabetes in tertiary care-a SwissDiab study [J].
Singeisen, Helene ;
Renstrom, Frida ;
Laimer, Markus ;
Lehmann, Roger ;
Bilz, Stefan ;
Brandle, Michael .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (14) :1473-1481
[34]   Oral semaglutide in patients with type 2 diabetes and cardiovascular disease, renal impairment, or other comorbidities, and in older patients [J].
Mosenzon, Ofri ;
Miller, Eden M. ;
Warren, Mark L. .
POSTGRADUATE MEDICINE, 2020, 132 :37-47
[35]   Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop [J].
Barnard-Kelly, Katharine ;
Battelino, Tadej ;
Brosius, Frank C. ;
Ceriello, Antonio ;
Cosentino, Francesco ;
Gavin III, James R. ;
Giorgino, Francesco ;
Green, Jennifer ;
Ji, Linong ;
Kellerer, Monika ;
Koob, Sue ;
Kosiborod, Mikhail ;
Lalic, Nebojsa ;
Marx, Nikolaus ;
Nedungadi, Prashant ;
Parkin, Christopher G. ;
Rodbard, Helena W. ;
Roetzer, Rene D. ;
Ryden, Lars ;
Sheu, Wayne Huey-Herng ;
Standl, Eberhard ;
Jeppesen, Britta Tendal ;
Topsever, Pinar ;
Vandvik, Per Olav ;
Wanner, Christoph ;
Schnell, Oliver .
CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
[36]   Risk factor control and incident cardiovascular disease in patients with diabetes: Sex-specific relations [J].
Wang, Xuan ;
Ma, Hao ;
Li, Xiang ;
Liang, Zhaoxia ;
Fonseca, Vivian ;
Qi, Lu .
DIABETES OBESITY & METABOLISM, 2024, 26 (04) :1421-1429
[37]   Current cholesterol guidelines and clinical reality: a comparison of two cohorts of coronary artery disease patients [J].
Vonbank, Alexander ;
Saely, Christoph H. ;
Rein, Philipp ;
Sturn, Daniel ;
Drexel, Heinz .
SWISS MEDICAL WEEKLY, 2013, 143
[38]   Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36) [J].
Yokoyama, H. ;
Araki, S. ;
Kawai, K. ;
Hirao, K. ;
Oishi, M. ;
Sugimoto, K. ;
Sone, H. ;
Maegawa, H. ;
Kashiwagi, A. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (03) :485-492
[39]   Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-based Study in South Korea [J].
Kim, Siin ;
Kim, Hyungtae ;
Kim, Eunju ;
Han, Sola ;
Rane, Pratik P. ;
Fox, Kathleen M. ;
Zhao, Zhongyun ;
Qian, Yi ;
Suh, Hae Sun .
CLINICAL THERAPEUTICS, 2018, 40 (06) :940-951
[40]   The effect of statins on mortality and cardiovascular disease in primary care hypertensive patients without other cardiovascular disease or diabetes [J].
Andersson, Tobias ;
Natman, Jonatan ;
Mourtzinis, Georgios ;
Bager, Johan-Emil ;
Bostrom, Kristina Bengtsson ;
Franzen, Stefan ;
Hjerpe, Per .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (17) :1883-1894
12345